Skip to content

Cardinal Health CAH Stock-Based Comp

Stock-Based Comp at other companies

Eli Lilly logo
Eli LillyLLY
$161M+4.5%
Cencora logo
CencoraCOR
$28M-1.6%
AbbVie logo
AbbVieABBV
$444M+8.3%
Avanos Medical logo
Avanos MedicalAVNS
$3.7M-2.6%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$8.82M+21.5%
AdaptHealth logo
AdaptHealthAHCO
$6.53M+23.3%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$55.72B+42.2%
Enterprise value$60.7B+35.3%
P/E35.8×+10.7×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's stock-based comp?
Cardinal Health (CAH) reported stock-based comp of $129M in Q1 2026.
How has Cardinal Health's stock-based comp changed year-over-year?
Cardinal Health's stock-based comp increased by 316.1% year-over-year, from $31M to $129M.
What is the long-term trend for Cardinal Health's stock-based comp?
Over 3 years (2022 to 2025), Cardinal Health's stock-based comp has grown at a 44.4% compound annual growth rate (CAGR), from $81M to $244M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.